1. Cylindrocarpon lichenicola keratomycosis in Nigeria: the challenge of limited access to effective antimicrobials
- Author
-
Patrick Agadaigho Udonwa, Oyekola V Abiri, AO Adeoye, Temitope O Obadare, Olajumoke Laoye, Emmanuel O Irek, and Aaron O. Aboderin
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Visual acuity ,genetic structures ,030106 microbiology ,Clinical Biochemistry ,Keratitis ,03 medical and health sciences ,0302 clinical medicine ,Natamycin ,medicine ,030212 general & internal medicine ,Corneal Scar ,Cylindrocarpon ,Voriconazole ,biology ,business.industry ,Public Health, Environmental and Occupational Health ,Mucopurulent discharge ,biology.organism_classification ,medicine.disease ,corneal ulcer ,Dermatology ,eye diseases ,Surgery ,Medical Laboratory Technology ,medicine.symptom ,business ,medicine.drug - Abstract
Introduction: We report a rare cause of keratitis, due to Cylindrocarpon lichenicola, in a farmer with keratomycosis. Despite the acknowledged virulence of this fungus, a suitable antifungal for its management was not accessible.Case presentation: A 67-year-old farmer presented with a two-week history of pain, mucopurulent discharge, redness and a corneal ulcer with a visual acuity of hand movement in the right eye. With a working diagnosis of infective keratitis, corneal scrapings were taken under a slit lamp biomicroscope for microbiological testing. Direct lactophenol cotton blue mounts revealed septate fungal hyphae, while fungal culture on Sabouraud dextrose agar at room temperature grew woolly mould phenotypically consistent with C. lichenicola.Management and outcome: The patient was started on hourly topical natamycin (5%), ciprofloxacin (0.3%), two-hourly instillation of tobramycin (0.3%) and atropine (1%) twice daily for three months following the isolation of the fungus. The eye healed with a corneal scar and no improvements in visual acuity.Discussion: This infection was difficult to manage due to the inaccessibility of a suitable antifungal, namely, voriconazole in our setting. Hence, there is a need for prompt identification and early institution of suitable antifungals in any patient with suspected keratomycosis.
- Published
- 2017
- Full Text
- View/download PDF